173 related articles for article (PubMed ID: 2209812)
1. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
[TBL] [Abstract][Full Text] [Related]
2. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
[TBL] [Abstract][Full Text] [Related]
3. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
4. IgG and IgM antibody responses to pneumococcal vaccination in splenectomized children and in children who had non-operative management of splenic rupture.
Kalin M; Linné T; Eriksson M; Lännergren K; Tordal P; Jakobsson B; Lundmark KM
Acta Paediatr Scand; 1986 May; 75(3):452-6. PubMed ID: 3728005
[TBL] [Abstract][Full Text] [Related]
5. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats.
Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA
J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606
[TBL] [Abstract][Full Text] [Related]
6. [Factors Influencing Pneumococcal Vaccination-Induced Total IgG, IgG2, and IgA Levels in Vaccinated Splenectomized Patients].
Gazi U; Derici MK; Karasartova D; Güreser AS; Şahiner İT; Dolapçı M; Taylan Özkan A
Mikrobiyol Bul; 2022 Jan; 56(1):103-113. PubMed ID: 35088964
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.
Petrasch S; Kühnemund O; Reinacher A; Uppenkamp M; Reinert R; Schmiegel W; Lütticken R; Brittinger G
Clin Diagn Lab Immunol; 1997 Nov; 4(6):635-8. PubMed ID: 9384280
[TBL] [Abstract][Full Text] [Related]
8. IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma.
Aaberge IS; Heier HE; Hem E; Giercksky KE; Groeng EC
Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):11-6. PubMed ID: 6711306
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease.
Frederiksen B; Specht L; Henrichsen J; Pedersen FK; Pedersen-Bjergaard J
Eur J Haematol; 1989 Jul; 43(1):45-9. PubMed ID: 2767242
[TBL] [Abstract][Full Text] [Related]
10. Response to pneumococcal vaccine among children with Hodgkin's disease.
Donaldson SS; Vosti KL; Berberich FR; Cox RS; Kaplan HS; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S133-43. PubMed ID: 6895119
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma.
Aaberge IS; Heier HE
Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):363-9. PubMed ID: 6524388
[TBL] [Abstract][Full Text] [Related]
12. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report.
Addiego JE; Ammann AJ; Schiffman G; Baehner R; Higgins G; Hammond D
Lancet; 1980 Aug; 2(8192):450-2. PubMed ID: 6106099
[TBL] [Abstract][Full Text] [Related]
13. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoglobulin levels in splenectomized Hodgkin patients and in subjects following post-traumatic splenectomy.
Douer D; Chaimoff C; Pick AI; Pinkhas J
Oncology; 1981; 38(3):165-7. PubMed ID: 7207953
[TBL] [Abstract][Full Text] [Related]
15. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
Siber GR; Weitzman SA; Aisenberg AC
Rev Infect Dis; 1981; 3 Suppl():S144-59. PubMed ID: 7280445
[TBL] [Abstract][Full Text] [Related]
16. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
[TBL] [Abstract][Full Text] [Related]
17. Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides.
Giebink GS; Le CT; Schiffman G
J Pediatr; 1984 Oct; 105(4):576-82. PubMed ID: 6481533
[TBL] [Abstract][Full Text] [Related]
18. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.
Cherif H; Landgren O; Konradsen HB; Kalin M; Björkholm M
Vaccine; 2006 Jan; 24(1):75-81. PubMed ID: 16107293
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
Landesman SH; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
[TBL] [Abstract][Full Text] [Related]
20. Surgical diseases of the spleen.
Baesl TJ; Filler RM
Surg Clin North Am; 1985 Oct; 65(5):1269-86. PubMed ID: 3904046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
